Key milestones
1997
REPER-NN is founded; production of pilot samples developed together with Russian eye care scientists
2004
Introduction of the unique material called Reperen; full production cycle is launched. First Russian soft IOL. First patents for the photochemical polymerisation technology
2014
International quality certification ISO 13485. The right to use the CE mark is granted
2016
Every fifth IOL implanted in Russia is manufactured by REPER-NN
2019
REPER-NN becomes a member of the international group of companies Rayner. A number of technology transfers are completed, including transfers to European countries
2020s — up to present time
Production modernisation and launch of new lens makes
The leading Russian eye care specialists talk about the high quality of eye lens manufactured by Reper — about their optic characteristics and stability of results in long-term post-surgery period. Such performance meets the global standards, which has been validated by numerous studies.
Glaucoma
Antiglaucomatous implants by Reper have been developed for surgical treatment of glaucoma. Due to their manufacturing technology, they are biocompatible with eye tissues. The risk of biological degradation of implants during long-term implantation in the eye has been precluded
